Seasonal Influenza Vaccine Effectiveness, 2017-2018
Age | Number | % Total |
---|---|---|
6 months-8 years | 504 | 24 |
9-17 years | 399 | 19 |
18-49 years | 732 | 34 |
50-64 years | 291 | 14 |
65+ years | 186 | 9 |
3Missing 16 subjects data
Gender | Number | % Total |
---|---|---|
Male | 820 | 39 |
Female | 1,308 | 61 |
On This Page
- Patients by Age
- Patients by Gender
- Patients by Race
- Influenza Virus Type And Subtype Among Influenza-Positive Patients
- Vaccine Effectiveness for all Vaccine Types Against influenza A or B viruses
- Vaccine Effectiveness for all Vaccine Types Against Influenza A (H3N2) viruses
- Vaccine Effectiveness for all Vaccine Types Against Influenza B/Yamagata lineage viruses
Race | Number | % Total |
---|---|---|
White, non-Hispanic | 1,215 | 57 |
Black, non-Hispanic | 208 | 10 |
Hispanic | 554 | 26 |
Other, non-Hispanic | 151 | 7 |
3Flannery et. Al, 2018
Top of Page Top of Page- Page last reviewed: September 4, 2018
- Page last updated: September 4, 2018
- Content source:
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
- Page maintained by: Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs